Back to search

Switzerland· 69692001

Yselty 100 mg, comprimés pelliculés

A linzagolix product containing linzagolixum, registered in Switzerland by Labatec Pharma SA and dispensed under Swissmedic category B. The same ATC class is registered in 12 of our 19 countries.

Cat B (Swissmedic)ATC H01CC04

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedYselty 100 mg, comprimés pelliculésATCH01CC04REGISTER NO.69692001PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Linzagolix is registered in 12 of 19 countries.

Countries holding a registration under ATC H01CC04 (linzagolix), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Linzagolix · ATC H01CC04

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of linzagolix costs, country by country.

Normalised to the WHO defined daily dose (0.13 g), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Linzagolix · price per daily dose (0.13 g)

USD · FX 28 Sept 2026

  • IT Italy$6.85
  • ES Spain$5.81
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
linzagolixum
Manufacturer
Labatec Pharma SA
Country
Switzerland (CH)
ATC code
H01CC04
ATC class
Linzagolix
Defined daily dose
0.13 g, O
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Linzagolix in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All linzagolix products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Yselty
  • Liechtenstein · Yselty
  • Norway · Yselty

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/75845693-52a8-47be-925c-c9d29d9b1571
GET /v1/drugs/75845693-52a8-47be-925c-c9d29d9b1571?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}

See everything about linzagolix.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.